(CG) Centerra Gold - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA1520061021

CG: Gold, Copper, Molybdenum

Centerra Gold Inc. is a gold mining company that operates through the entire mining lifecycle, from acquisition and exploration to development and operation of gold and copper properties. The company's geographical footprint spans North America, Turkey, and other international locations, providing a diversified portfolio of assets. Its exploration efforts are focused on discovering gold, copper, and molybdenum deposits, which are essential metals in various industrial applications. By leveraging its expertise in mining operations, Centerra Gold aims to create value for its stakeholders through the efficient extraction and processing of these valuable resources.

The company's portfolio of assets includes several notable projects, with the Mount Milligan gold-copper mine in British Columbia, Canada, being one of its flagship operations. As a 100% owned asset, Mount Milligan provides Centerra Gold with a significant source of gold and copper production, contributing to the company's overall revenue and profitability. Another key project is the Öksüt gold mine in Turkey, which offers further growth opportunities for the company. With a strong foundation in these core assets, Centerra Gold is well-positioned to navigate the complexities of the global mining industry and capitalize on emerging trends and opportunities.

As a Canadian-based company, Centerra Gold Inc. is incorporated in the province of Ontario and is listed on the Toronto Stock Exchange. The company's website, https://www.centerragold.com, provides investors and stakeholders with access to detailed information about its operations, financial performance, and governance practices. With an ISIN of CA1520061021, Centerra Gold's common stock is classified under the GICS Sub Industry: Gold, reflecting its primary focus on gold mining and related activities. This classification helps investors and analysts to better understand the company's business model and compare its performance with that of its peers in the gold mining sector.

Additional Sources for CG Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CG Stock Overview

Market Cap in USD 1,239m
Sector Basic Materials
Industry Gold
GiC Sub-Industry Gold
IPO / Inception

CG Stock Ratings

Growth 5y 38.4%
Fundamental 34.5%
Dividend 76.9%
Rel. Strength Industry 34.6
Analysts -
Fair Price Momentum 9.89 CAD
Fair Price DCF 21.83 CAD

CG Dividends

Dividend Yield 12m 19.29%
Yield on Cost 5y 32.37%
Annual Growth 5y 7.32%
Payout Consistency 61.8%

CG Growth Ratios

Growth Correlation 3m 4.6%
Growth Correlation 12m 61.3%
Growth Correlation 5y 24.1%
CAGR 5y 10.92%
CAGR/Mean DD 5y 0.35
Sharpe Ratio 12m 1.13
Alpha 28.42
Beta 0.76
Volatility 42.18%
Current Volume 367.6k
Average Volume 20d 523.6k
What is the price of CG stocks?
As of January 29, 2025, the stock is trading at CAD 8.71 with a total of 367,600 shares traded.
Over the past week, the price has changed by +0.93%, over one month by +9.15%, over three months by -7.97% and over the past year by +46.73%.
Is Centerra Gold a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Centerra Gold is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.47 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CG as of January 2025 is 9.89. This means that CG is currently undervalued and has a potential upside of +13.55% (Margin of Safety).
Is CG a buy, sell or hold?
Centerra Gold has no consensus analysts rating.
What are the forecast for CG stock price target?
According to ValueRays Forecast Model, CG Centerra Gold will be worth about 10.7 in January 2026. The stock is currently trading at 8.71. This means that the stock has a potential upside of +22.96%.
Issuer Forecast Upside
Wallstreet Target Price 12.1 38.7%
Analysts Target Price - -
ValueRay Target Price 10.7 23%